Cochrane Austria, Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria (G.W., A.D., A.T., A.C., E.P., I.K.)
Auto-generated profile, based on publicly available information
Ana Toromanova
Cochrane Austria, Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria (G.W., A.D., A.T., A.C., E.P., I.K.)
This systematic review and network meta-analysis summarizes studies on the effectiveness of different pharmacologic, nonpharmacologic, and alternative interventions for initial and second-line trea... Background: Primary care patients and clinicians may prefer alternative options to second-generation antidepressants for major depressive disorder (MDD). Purpose: To compare the benefits and harms ...
This rapid review summarizes studies on patient values and preferences for initial or second-line treatment of major depression. Background: Developers of clinical practice guidelines need to take patient values and preferences into consideration when weighing benefits and harms of treatment options for depressive disorder. ...